Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study - Marinelli, B; Kim, E; DʼAlessio, A (J Immunother Cancer, 2022)
et al.